Genes and Development

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pedersen, T. A.
Right arrow Articles by Nerlov, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pedersen, T. A.
Right arrow Articles by Nerlov, C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Vol. 15, No. 23, pp. 3208-3216, December 1, 2001

RESEARCH PAPER
Cooperation between C/EBPalpha TBP/TFIIB and SWI/SNF recruiting domains is required for adipocyte differentiation

Thomas Åskov Pedersen,1,3 Elisabeth Kowenz-Leutz,2,3 Achim Leutz,2,4 and Claus Nerlov1,4

1 Laboratory of Gene Therapy Research, Copenhagen University Hospital, 2100 Copenhagen, Denmark; 2 Max-Delbrück-Center for Molecular Medicine, 13125 Berlin, Germany


    ABSTRACT
Top
Abstract
Introduction
Results
Discussion
Materials and methods
References

Chromatin remodeling is an important step in promoter activation during cellular lineage commitment and differentiation. We show that the ability of the C/EBPalpha transcription factor to direct adipocyte differentiation of uncommitted fibroblast precursors and to activate SWI/SNF-dependent myeloid-specific genes depends on a domain, C/EBPalpha transactivation element III (TE-III), that binds the SWI/SNF chromatin remodeling complex. TE-III collaborates with C/EBPalpha TBP/TFIIB interaction motifs during induction of adipogenesis and adipocyte-specific gene expression. These results indicate that C/EBPalpha acts as a lineage-instructive transcription factor through SWI/SNF-dependent modification of the chromatin structure of lineage-specific genes, followed by direct promoter activation via recruitment of the basal transcription-initiation complex, and provide a mechanism by which C/EBPalpha can mediate differentiation along multiple cellular lineages.

[Key Words: Adipocyte; C/EBP; chromatin; differentiation; SWI/SNF; transcription]


    Introduction
Top
Abstract
Introduction
Results
Discussion
Materials and methods
References

The activation of cellular genes is a multistep process requiring modulation of promoter and enhancer chromatin structure as a prerequisite for the subsequent binding of specific and basal transcription factors that direct gene transcription. Modification of chromatin involves direct modification of the histones by kinases, methylases, and acetylases, as well as reorganization of nuclesome structure by chromatin remodeling machines (for review, see Muller and Leutz 2001). The role of chromatin remodeling in lineage-specific gene expression has been investigated in the globin locus, where it has been found that the erythroid Kruppel-like factor (EKLF) transcription factor recruits the SWI/SNF complex to the beta -globin promoter, resulting in displacement of nucleosomes from and hypersensitivity of the core promoter region (Armstrong et al. 1998; Lee et al. 1999). EKLF binding to the proximal beta -globin promoter region is required for beta -globin transcription in vivo, and EKLF-deficient mice die from severe beta -thalassemia (Perkins et al. 1995). Recently, it was reported that dominant-negative variants of the SWI/SNF catalytic core subunits, human Brahma (hBrm) and Brahma-related gene 1 (Brg1), which lack the ATPase activity necessary for chromatin remodeling, inhibit MyoD-dependent induction of muscle-specific gene transcription in fibroblasts (de La Serna et al. 2001). These observations indicate that SWI/SNF-mediated chromatin remodeling is an integral part of developmental decisions mediated by transcriptional activators.

C/EBPalpha , the founding member of the C/EBP family, was originally isolated as an activator of liver-specific transcription. Subsequently, C/EBP proteins have been shown to regulate the differentiation of several cell types. C/EBPalpha is required in vivo for the differentiation of adipocytes, neutrophil granulocytes, and eosinophils (Wang et al. 1995; Zhang et al. 1997). Moreover, C/EBPalpha is capable of inducing uncommitted progenitors to differentiate along the granulocyte, eosinophil, and adipose lineages (Freytag et al. 1994; Nerlov et al. 1998; Radomska et al. 1998), classifying it as a lineage instructive transcription factor. The induction of eosinophil lineage commitment by C/EBPs appears to be caused by their ability to down-regulate the expression of the Friend of GATA (FOG) protein, allowing cooperative activation by C/EBP proteins and GATA-1 (Querfurth et al. 2000). The activation of chromatin-embedded myeloid genes in heterologous cell types, such as fibroblasts, has been accomplished by a combination of Myb and C/EBP transcription factors (Burk et al. 1993; Ness et al. 1993), and this has been shown to involve the recruitment of the SWI/SNF chromatin-remodeling complex by the N-terminal CR1 region of C/EBPbeta (Kowenz-Leutz and Leutz 1999). In the case of the adipose lineage, the molecular mechanisms are less clear. The inductive role of C/EBPalpha in adipogenesis has been correlated to its ability to up-regulate the expression of PPARgamma (Wu et al. 1999), an essential in vivo regulator of adipogenesis (Barak et al. 1999; Lowell 1999; Rosen et al. 1999), as well as the ability of C/EBPalpha to directly activate adipocyte-specific promoters (Christy et al. 1989; Cheneval et al. 1991).

To address the molecular mechanisms underlying adipocyte differentiation, we have determined the structural requirements for C/EBPalpha -mediated conversion of uncommitted fibroblast precursors to adipocytes. We find that the C/EBPalpha transactivation element III (TE-III; Nerlov and Ziff 1994) is required for adipose conversion, as well as activation of chromatin-embedded myeloid- and adipocyte-specific genes, including PPARgamma . This region of C/EBPalpha interacts with the SWI/SNF chromatin remodeling complex, and collaborates with TBP/TFIIB-interacting motifs in C/EBPalpha during adipogenesis, indicating that integration of chromatin remodeling and recruitment of basal transcription factors forms the basis for the lineage instructive capacity of C/EBPalpha .


    Results
Top
Abstract
Introduction
Results
Discussion
Materials and methods
References

The C/EBPalpha TE-III is required for adipose conversion of NIH3T3 fibroblasts

C/EBPalpha is able to mediate the transition of uncommitted mesenchymal precursor cells to mature adipocytes (Freytag et al. 1994). In the case of NIH3T3 fibroblasts, induced adipogenesis occurs without up-regulation of the endogenous C/EBPalpha gene (Wu et al. 1995; Yeh et al. 1995), making this system well-suited for structure-function analysis of C/EBPalpha . We infected subconfluent NIH3T3 cultures with pBabePuro-based virus expressing wild-type C/EBPalpha , as well as C/EBPalpha lacking each of the three identified C/EBPalpha transactivation elements (TE-I through III; Nerlov and Ziff 1994) or amino acids 200-256, containing the putative GSK3 (T222,T226,S230; Ross et al. 1999) and PKC (S248) phosphorylation sites in C/EBPalpha (Fig. 1A). These experiments showed that TE-I and TE-III were required for the induction of expression of the lipoprotein lipase (LPL), PPARgamma , and aP2 mRNAs (Fig. 1B), all coding for proteins characteristically expressed in adipocytes. Deletion of TE-II or the GSK3 and PKC phosphorylation sites (aa 200-256) did not significantly affect C/EBPalpha -mediated induction of adipocyte gene expression (Fig. 1B), which occurred with kinetics comparable to cells transduced with wild-type C/EBPalpha (data not shown). For all mutants, gene expression correlated with morphological adipocyte differentiation and triglyceride accumulation induced by the C/EBPalpha alleles (Porse et al. 2001). Stability of the various mutant C/EBPalpha proteins did not appear to play a role in their differential ability to induce adipocyte differentiation, as judged by their similar expression levels determined by Western blotting (Fig. 1C).



View larger version (46K):
[in this window]
[in a new window]
 
Figure 1.   C/EBPalpha domains required for adipogenesis in vitro. (A) Domain structure of the C/EBPalpha protein. The transactivation elements (TE) I through III, the phosphorylation sites for glycogen synthase kinase 3 (GSK3), and protein kinase C (PKC), and the basic region-leucine zipper (BR-LZ) DNA binding domain are indicated. (B) NIH3T3 fibroblasts were transduced with pBabePuro (vector), pBabePuro-based retrovirus encoding wild-type C/EBPalpha , or C/EBPalpha derivatives lacking TE-I (D1-70), TE-II (D70-96), TE-III (D126-200), or the GSK3 and PKC phosphorylation sites (D200-256). After 2 wk of selection for expression of the retroviral construct total cellular RNA was analyzed for the presence of the following mRNAs by Northern blotting: lipoprotein lipase (LPL), peroxisome-proliferator activating receptor gamma  (PPARgamma ), aP2-422 (aP2), and glyceraldehyde phosphate dehydrogenase (GAPDH). (C) Parallel cultures were lysed in SDS sample buffer and equivalent amounts of total cellular protein analyzed for C/EBPalpha expression by Western blotting using the C103 anti-C/EBPalpha antibody. Bands corresponding to C/EBPalpha derivatives are indicated with asterisks.

The C/EBPalpha TE-III is required for interaction with the SWI/SNF chromatin remodeling complex

The functions embedded in the essential TE-I and TE-III regions were further examined. We have found TE-I to be necessary for the ability of C/EBPalpha to repress E2F mediated transcription, and that this is required for adipocyte differentiation (Porse et al. 2001). The function of TE-III was suggested by the observation that this region has little homology in other C/EBPs, including C/EBPbeta . The distinct properties of C/EBPalpha and C/EBPbeta were addressed recently by in vivo gene replacement by Chen et al. (2000), who substituted the mouse C/EBPalpha coding sequence with that of C/EBPbeta (generating mice with the C/EBPalpha beta /beta genotype), and observed that differentiation of white adipose tissue was severely impaired. The C/EBPbeta coding sequence used to replace C/EBPalpha lacked the murine equivalent of the C/EBPbeta CR1 SWI/SNF interaction domain (Kowenz-Leutz and Leutz 1999). This suggested that the lack of proper adipocyte differentiation in the C/EBPalpha beta /beta mice was caused by a defect in SWI/SNF recruitment. We therefore tested the ability of C/EBPalpha to interact with SWI/SNF components, and whether TE-III was necessary and sufficient for this interaction. For this purpose, full-length C/EBPalpha (p42), C/EBPalpha p30 (a C/EBPalpha form initiated from the in-frame methionine at position 118), and a deletion mutant lacking the entire transactivation domain, including TE-III, (D1-215; Fig. 2A) were C-terminally FLAG-tagged and cotransfected with HA-tagged hBrm into the Brahma-negative C33A cell line. The ability of these C/EBPalpha derivatives to interact with hBrm was then analyzed by immunoprecipitation with the M2 anti-FLAG monoclonal antibody, followed by Western blot analysis of the immunoprecipitate with the PBR-205C monoclonal anti-HA antibody (Fig. 2B). In this assay the C/EBPalpha p42 and p30 proteins, but not C/EBPalpha D1-215, were found to associate with hBrm, consistent with TE-III being a C/EBPalpha SWI/SNF interaction domain. Indeed, deletion of TE-III was sufficient to eliminate the C/EBPalpha -hBrm coprecipitation (Fig. 2C). Furthermore, after deletion of TE-III, hBrm coprecipitation could be restored by fusing the heterologous CR1 SWI/SNF recruiting domain from C/EBPbeta to the C/EBPalpha N terminus (Fig. 2A and C, lane 7). The BAF155 core SWI/SNF subunit also coprecipitated with C/EBPalpha (Fig. 2C). These results show that TE-III is both necessary and sufficient for C/EBPalpha to interact with the core SWI/SNF complex in a cellular setting, and that the structurally unrelated CR1 domain from C/EBPbeta can functionally replace TE-III in this respect. Furthermore, these results show that the N-terminal part (amino acids 1-117) of the C/EBPalpha transactivation domain unique to C/EBPalpha p42 is not required for SWI/SNF interaction by C/EBPalpha .



View larger version (47K):
[in this window]
[in a new window]
 
Figure 2.   Interaction between TE-III and the SWI/SNF complex. (A) Structure of the C/EBPalpha derivatives used for coimmunoprecipitation assays. The transactivation elements (TE-) I through III, and the basic region-leucine zipper DNA binding domain (BR-LZ) are indicated. CR1 is the conserved region 1 from C/EBPbeta (Kowenz-Leutz et al. 1994). All C/EBPalpha derivatives were C-terminally FLAG tagged for coimmunoprecipitation analysis. (B,C) 5 × 106 C33A cells were calcium phosphate-transfected with 5µg of the indicated CMV-driven C/EBPalpha -FLAG and HA-hBrm expression vectors. Lysates were prepared and immunoprecipitated (IP) with M2 anti-FLAG antibody (FLAG) or with nonimmune serum (non-immune). Precipitated proteins were detected by Western blotting with PRB-205C antiHA monoclonal antibody (HA-hBrm), M2 anti-FLAG monoclonal antibody (C/EBPalpha -FLAG) and anti-BAF155 polyclonal antibody (BAF155). Western blot analysis of the lysates used for immunoprecipitation is shown (lysate) to verify the expression of the various input proteins.

The ability of C/EBPalpha TE-III to function as a SWI/SNF-recruiting domain on chromosomal loci was tested by analyzing the C/EBPalpha -mediated induction of the mim-1 and #126 myeloid-specific transcripts (Ness et al. 1993). Both of these genomic loci are activated by C/EBPbeta in a SWI/SNF-dependent manner in nonmyeloid cell types, and in the case of mim-1 in collaboration with Myb (Kowenz-Leutz and Leutz 1999). QT6 cells were transfected with wild-type C/EBPalpha and selected derivatives, both in the presence and the absence of c-Myb expression, and the expression of mim-1 and #126 was analyzed by Northern blotting (Fig. 3A). C/EBPalpha efficiently activated both #126 and mim-1 transcription, the latter in collaboration with c-Myb. This activation was strongly diminished by deletion of TE-III. However, TE-III deletion could be functionally compensated by N-terminal addition of the C/EBPbeta CR1 domain. Similar results were obtained in HD3 erythroblasts; here Myb is already present, and strong TE-III-dependent activation of mim-1 transcription was observed (Fig. 3B). Again TE-III could be functionally replaced by CR1. The activation of the #325 locus, which is activated by C/EBPbeta in a SWI/SNF independent manner (Kowenz-Leutz and Leutz 1999), is shown as a control for the presence of C/EBPalpha transactivation in all cases. Together these data show that C/EBPalpha TE-III mediates activation of SWI/SNF-dependent chromosomal loci, indicating that it indeed has SWI/SNF recruiting activity, and that this is a required function during C/EBPalpha -mediated activation of myeloid-specific transcription.



View larger version (40K):
[in this window]
[in a new window]
 
Figure 3.   TE-III dependent activation of chromosomal myeloid-specific loci. (A) Poly(A) RNA from 8 × 106 QT6 fibroblasts transfected with CMV-C/EBPalpha expression vectors and pCRNCM-Myb expression vector (+) or the corresponding empty expression vectors, was analyzed by Northern blotting for expression of the myeloid-specific mim-1 and #126 transcripts, and for expression of GAPDH mRNA as an internal control. (B) Poly(A) RNA from 2 × 107 HD3 cells transfected with the indicated CMV-C/EBPalpha expression vectors was analyzed by Northern blotting for expression of the myeloid-specific mim-1, #325, and GAPDH transcripts.

SWI/SNF recruitment is essential for C/EBPalpha -mediated adipogenesis

To assess whether SWI/SNF recruitment was the essential function of TE-III during adipocyte differentiation, we transduced NIH3T3 cells with retrovirus encoding C/EBPalpha , the TE-III deletion mutant, or the CR1 add-back protein. As can be seen from Figure 4A, this analysis showed that although deletion of TE-III strongly reduced morphological adipocyte differentiation, the CR1 domain could efficiently rescue the ability of C/EBPalpha to induce morphological adipocyte differentiation (Fig. 4A). Analysis of adipocyte-specific gene expression showed that the ability of C/EBPalpha to activate endogenous adipocyte-specific genes (with kinetics comparable to wild-type C/EBPalpha ; data not shown), including that of PPARgamma , was abolished by progressive deletion of TE-III, and restored by the CR1 add-back (Fig. 4B). The level of rescue was estimated by quantification of triglyceride accumulation and aP2 mRNA (Fig. 4C), and found to be 50% and 70%, respectively. The <100% rescue efficiency may be caused by the presence of both SWI/SNF recruiting and direct transactivation functions within TE-III, only the former being supplied by CR1 (see Discussion).



View larger version (65K):
[in this window]
[in a new window]
 
Figure 4.   Rescue of adipogenesis by the C/EBPbeta CR1 domain. NIH3T3 cells were infected with pBabePuro control virus (vector) or virus encoding the indicated C/EBPalpha derivatives and allowed to differentiate for 2 wk. Adipocyte morphology was analyzed by Oil Red O staining (A), and expression of the LPL, PPARgamma , and aP2 adipocyte mRNAs and C/EBPalpha protein determined (B) as in Figure 1B. (C) Level of adipocyte differentiation determined by quantitative Oil Red O staining (red columns; error bars indicate standard deviations; n = 3) and measurement of aP2 mRNA accumulation (after normalization to GAPDH) for the indicated C/EBPalpha alleles. The background value obtained from cells transduced with empty vector have been subtracted.

To further investigate the correlation between SWI/SNF recruitment and activation of adipocyte gene expression by C/EBPalpha , we introduced point mutations into residues of CR1 conserved in vertebrate C/EBPbeta molecules (Fig. 5A). CR1 was chosen for this analysis rather than TE-III, because the latter, in addition to its SWI/SNF recruiting activity, harbors activating functions and negative regulatory elements (Friedman and McKnight 1990; Nerlov and Ziff 1994) that could potentially confound the analysis. These CR1 mutations were introduced into the C/EBPalpha D126-200+CR1 background and analyzed for their effect on SWI/SNF interaction in coimmunoprecipitation assays (as in Fig. 2). The mutations were found to inhibit (mutLL, mutFR) or abolish (mutWD) the interaction of the C/EBPalpha D126-200+CR1 molecule and the SWI/SNF complex, as determined by coimmunoprecipitation of HA-hBrm (Fig. 5B, panel a), even though the mutant proteins were expressed and immunoprecipitated at the same level as the wild-type CR1 fusion (Fig. 5B, panels b and d). The deficiencies of these mutant molecules in direct SWI/SNF interaction were paralleled by their decreased ability to activate the SWI/SNF-dependent mim-1 locus after cotransfection into HD3 erythroblasts (Fig. 5C), as well as aP2 gene expression (Fig. 5D) and morphological differentiation (data not shown) in NIH3T3 cells on retroviral transduction. A strong correlation therefore exists between SWI/SNF recruitment, the ability to activate of SWI/SNF-dependent loci, and the adipogenic potential of CR1.



View larger version (57K):
[in this window]
[in a new window]
 
Figure 5.   Mutation analysis of CR1. (A) Amino acid sequence of mouse CR1, indicating the positions of residues mutated to alanines in the mutLL, mutWD, and mutFR CR1 variants, respectively. (B) Coimmunoprecipitation analysis of C/EBPalpha D126-200+CR1 and its mutant derivatives was performed as in Figure 2B. The HA-hBrm coprecipitated with the C/EBPalpha -FLAG-derivatives is shown in panel a, the precipitated C/EBPalpha -FLAG in panel b. The levels of the same proteins in the input lysate for the coimmunoprecipitation are shown in panels c and d, respectively. (C) The ability of C/EBPalpha D126-200+CR1 and its mutant derivatives to induce mim-1 expression in HD3 erythroblasts was analyzed as in Figure 3B. (D) The induction of aP2 mRNA in retrovirally transduced NIH3T3 cells determined as in Figure 1B.

SWI/SNF and TBP/TFIIB binding motifs of C/EBPalpha cooperate during adipocyte differentiation

The C/EBPalpha transactivation domain contains amino acid motifs, conserved between the activating C/EBP isoforms, which interact with the basal transcriptional machinery, both in vitro and in a cellular context (Nerlov and Ziff 1995). These motifs reside in the N-terminal part of the C/EBPalpha transactivation domain, which is not required for SWI/SNF interaction. Therefore, we introduced into NIH3T3 cells a version of C/EBPalpha in which residues critical for its interaction with the basal transcription factors TBP and TFIIB have been mutated (C/EBPalpha Y67A, FL77, 78AA, or YFL, mutant; Nerlov and Ziff 1995), and analyzed the effect on adipogenesis and adipocyte-specific gene expression. NIH3T3 cells transduced with C/EBPalpha YFL differentiated poorly, both by morphological criteria (Fig. 6A) and as measured by their expression of LPL, PPARgamma , and aP2 mRNAs (Fig. 6B). Quantification of Oil Red O staining and aP2 mRNA expression indicated a 80%-90% loss of adipogenic potential in the YFL mutant (Fig. 6C), despite expression of the mutant protein to a similar extent as wild-type C/EBPalpha (Fig. 6D). These results show that the C/EBPalpha TBP/TFIIB interaction motifs are required for C/EBPalpha -mediated activation of the chromosomal loci encoding the adipocyte-specific markers LPL, PPARgamma , and aP2.



View larger version (89K):
[in this window]
[in a new window]
 
Figure 6.   Requirement of C/EBPalpha TBP/TFIIB interaction motifs for adipogenesis. NIH3T3 cells were infected with pBabePuro control virus (vector), virus encoding wild-type (WT) C/EBPalpha , or the Y67A, FL77,78AA C/EBPalpha mutant (YFL) and allowed to differentiate for 2 wk. Parallel cultures were analyzed for morphological adipocyte differentiation (A) and expression of the LPL, PPARgamma , and aP2 adipocyte mRNAs (B) as in Figures 4A and 1B, respectively. Quantification of accumulated triglyceride (by Oil Red O staining) and aP2 mRNA (C) was done as in Figure 4C, and C/EBPalpha protein (D) as in Figure 1C.


    Discussion
Top
Abstract
Introduction
Results
Discussion
Materials and methods
References

SWI/SNF action in differentiation and lineage-specific gene expression

The results presented here show that C/EBPalpha interacts with the SWI/SNF complex via its TE-III, and that TE-III is required for C/EBPalpha -mediated activation of SWI/SNF-dependent myeloid genes, as well as for C/EBPalpha -mediated adipogenesis. The structurally unrelated C/EBPbeta CR1 SWI/SNF recruiting domain could replace TE-III, and mutation of residues within CR1 that compromised its SWI/SNF recruiting capacity reduced or abolished its ability to compensate for deletion of TE-III. Together, these results strongly support that SWI/SNF recruitment is the critical function of TE-III, which is complemented by CR1. In addition to the SWI/SNF recruiting function identified here, TE-III has been shown previously to participate in direct promoter activation (Friedman and McKnight 1990; Nerlov and Ziff 1994), which is not the case for CR1 (Kowenz-Leutz and Leutz 1999). This is likely to account for <100% rescue of adipocyte gene expression that we observe. Previous reports have shown that SWI/SNF is involved in the transcription of the erythroid lineage-specific beta -globin locus and in activation of chromosomal myeloid-specific loci (Armstrong et al. 1998; Kowenz-Leutz and Leutz 1999; Lee et al. 1999). More recently, de la Serna et al. (2001) have shown that dominant-negative hBrm and Brg1 molecules block the induction of myogenesis and muscle-specific gene expression by MyoD in NIH3T3 cells. The present results show that SWI/SNF recruitment by a lineage-specific transcription factor directly mediates lineage commitment and differentiation in a mammalian species, and in addition provide a molecular mechanism by which C/EBPalpha can mediate the differentiation of distinct cell types.

Generating specificity of C/EBPalpha  function

The C/EBPalpha transcription factor has the capability to execute various differentiation programs. In hematopoiesis, both eosinophil and neutrophil lineage commitment can be induced by C/EBPalpha (Nerlov et al. 1998; Radomska et al. 1998), and adipogenesis can be initiated by C/EBPalpha in uncommitted mesenchymal precursor cells (Freytag et al. 1994) or, in collaboration with PPARgamma , in myocytes (Hu et al. 1995). These observations suggest that C/EBPalpha provides a fundamental function generally required for the activation of specific differentiation programs, and that the collaborating factors (PPARgamma , GATA-1, Myb, PU.1) serve to direct this function to appropriate gene loci. The requirement for the SWI/SNF interacting TE-III domain of C/EBPalpha in both adipose conversion of NIH3T3 cells and in activation of SWI/SNF-dependent myeloid-specific gene expression (in the case of mim-1, in collaboration with c-Myb) provides evidence that the capacity to recruit SWI/SNF chromatin remodeling complexes is such a function. This is further supported by the previous demonstration that providing a "selector" molecule such as c-Myb (which by itself does not recruit SWI/SNF) with an SWI/SNF recruiting domain rendered it functionally independent of C/EBP activity for myeloid-specific gene activation (Kowenz-Leutz and Leutz 1999). Together, these observations lead us to propose that SWI/SNF recruitment is an integral part of C/EBPalpha -dependent (and C/EBPbeta -dependent) differentiation processes. As mentioned above, the inability of a C/EBPbeta molecule lacking the CR1 SWI/SNF binding domain to replace C/EBPalpha in adipogenesis, without affecting liver gene expression (Chen et al. 2000), provides in vivo evidence that SWI/SNF recruitment is indeed relevant for adipogenesis.

Collaboration between chromatin remodeling and direct promoter activation

Whereas the p42-specific part of the C/EBPalpha transactivation domain is dispensable for the interaction between C/EBPalpha and the SWI/SNF complex, it still harbors functions required for adipocyte (this paper) and eosinophil differentiation (Nerlov et al. 1998). Mutation of two TBP and TFIIB interaction motifs (Nerlov and Ziff 1995) that reside in this part of C/EBPalpha almost completely blocks induction of adipocyte-specific genes, demonstrating that abolishing the capacity of C/EBPalpha to interact with the basal transcription apparatus blocks C/EBPalpha -mediated adipogenesis. In vitro analysis of beta -globin promoter activation by EKLF has shown that SWI/SNF mediated promoter chromatin remodeling was necessary, but not sufficient, for promoter activity (Armstrong et al. 1998), and Imbalzano et al. (1994) have shown that SWI/SNF-mediated chromatin remodeling facilitates binding of TBP to a nucleosomal template. All these results are consistent with a model in which C/EBPalpha induces SWI/SNF-mediated chomatin remodeling, facilitating subsequent recruitment of the basal transcriptional machinery, and indicate that such mechanisms operate generally during cellular lineage commitment and differentiation.


    Materials and methods
Top
Abstract
Introduction
Results
Discussion
Materials and methods
References

DNA constructs

Rat C/EBPalpha deletion mutants (Nerlov and Ziff 1994) and transactivation domain point mutant (C/EBPalpha Y,FL; Nerlov and Ziff 1995) have been described previously. All C/EBPalpha derivatives were cloned into pBabePuro (Morgenstern and Land 1990) for retroviral infection as BamHI-EcoRI fragments. C/EBPalpha D126-200+CR1 and mutant derivatives were amplified by PCR from pBabePuro ralpha D126-200 using a 5' primer encoding the first 21 amino acids of full-length mouse C/EBPbeta (CR1; Kowenz-Leutz et al. 1994) or primers encoding mutant versions of CR1. The PCR fragment was cloned into pBabePuro using BamHI and EcoRI. All C/EBPalpha derivatives produced by PCR were confirmed by DNA sequencing. The pCRNCM and pCRNCM-Myb expression vector has been described previously (Lim et al. 1992). C-terminal FLAG tagging of C/EBPalpha was performed using an oligonucleotide adapter, and FLAG fusion proteins were expressed from pcDNA3 (Invitrogen).

Retroviral infection and adipocyte differentiation

NIH3T3 cells (provided by Dr. Karsten Kristiansen, University of Southern Denmark, Denmark) and Phoenix-E ecotropic retroviral packaging cells (from Dr. G. Nolan, Stanford University, San Francisco, California) were grown in Dulbecco's modified Eagles medium (DMEM) containing 10% FBS. Retroviral stocks were obtained by transiently transfecting Phoenix-E cells with pBabePuro-based proviral constructs using calcium phosphate coprecipitation. Forty-eight hours after transfection culture supernatants were harvested and filtered through 0.45 µm sterile filters (Millipore). The resulting viral stocks were used to infect subconfluent layers (30%-50% confluence) of NIH3T3 cells overnight in the presence of 100 µg/mL polybrene (Sigma). After infection, cells were cultured in DMEM plus 10% FBS (without any addition of adipogenic effectors) for 2 wk in puromycin-containing medium (1 µg/mL, Sigma) to allow differentiation to occur. Parallel cultures were used for preparation of total cellular protein or RNA preparation, or fixed and stained with Oil Red O (Ramirez-Zacarias et al. 1992).

Endogenous gene activation assay

HD3 erythroblasts and quail QT6 fibroblasts (Beug et al. 1979) were grown in DMEM supplemented with 8% fetal calf serum, 2% heat-inactivated chicken serum, and antibiotics. To monitor endogenous gene activation in HD3 or QT6 cells, 2 × 107 or 8 × 106 cells, respectively, were transfected with C/EBPalpha and Myb expression vectors using DEAE-dextran (Kowenz-Leutz et al. 1994), and RNA harvested 16-24 h posttransfection.

RNA isolation and Northern blotting

Total cellular RNA was prepared according to Chromzynski and Sacchi (1987). Poly(A) RNA was isolated using magnetic oligo(dT) beads according to the manufacturer's instructions (Dynal). RNA (25 µg of total RNA from NIH3T3 cells; poly(A) RNA from 2 × 107 HD3 cells or 8 × 106 QT6 cells) was run on a 1.2% agarose gel (in 20 mM MOPS at pH 7.0, 50 mM Na-acetate, 1 mM EDTA, and 1.5% formaldehyde) for 500 Vh. RNA was capillary blotted overnight onto BiodyneB membranes (Life Technologies) or Hybond N+ membranes (Amersham). Blots were prehybridized (30 min at 65°C) and hybridized (overnight at 65°C) in Quick-Hyb hybridization solution (Stratagene). Stringent washes were at 65°C in 0.2× SSC 0.1% SDS (60°C for QT6 and HD3 blots). The Northern blots were analyzed using a Fuji BAS2500 phosphorimager and ImageGauge software, or exposed to Kodak XAR X-ray film. cDNA probes were human LPL cDNA (Wion et al. 1987), mouse PPARgamma , and aP2 cDNAs (obtained from Dr. Karsten Kristiansen, University of Southern Denmark, Denmark), mouse GAPDH (Hanauer and Mandel 1984) and chicken mim-1, #126, and GAPDH (Nakano and Graf 1992). Probes were labeled with [alpha -32P]dCTP (Amersham-Pharmacia) using random priming (RadPrime; GIBCO BRL) according to the instructions supplied by the manufacturer.

Western blotting

Virally infected NIH3T3 cells were lysed in SDS sample buffer, incubated at 95°C for 5 min, centrifuged to remove insoluble components, and the lysates separated on 12.5% SDS-PAGE gels (200 Vh). Proteins were transferred to PVDF membranes (Millipore) using semi-dry transfer. Membranes were blocked in TBS-T (100 mM Tris at pH 7.5, 150 mM NaCl, 0.1% Tween 20) containing 10% nonfat dry milk overnight at 4°C, incubated with primary antibody (C103 rabbit anti-C/EBPalpha antiserum; Nerlov and Ziff 1994), PRB-205C anti-HA antibody (BAbCO, Freiburg, Germany), M2 anti-FLAG antibody (Sigma) or anti-BAF155 antiserum (Kowenz-Leutz and Leutz 1999) in TBS-T for 1 h at room temperature, followed by appropriate horseradish peroxidase-conjugated secondary antibody (Amersham-Pharmacia; 1:5000 in TBS-T; 1 h at room temperature) with three 5' washes in TBS-T after each incubation. Blots were developed using enhanced chemiluminescence (ECL; Amersham-Pharmacia).

Coimmunoprecipitation

A total of 5 × 106 C33A cells were transfected with 5 µg of the expression vectors indicated, using calcium phosphate coprecipitation. Cell lysates were prepared and immunoprecipitated as described previously (Kowenz-Leutz and Leutz 1999) using anti-FLAG M2 antibodies (Kodak). Immunoprecipitates were boiled in SDS sample buffer and subjected to Western blotting.


    Acknowledgments

We thank Drs. Kristian Helin, Karsten Kristiansen and Gary Nolan for kind gifts of plasmids and cell lines. This work was supported by the Danish Medical Research Council, the Danish Cancer Society, the Novo Nordisk Foundation (C.N.), and the Deutsche Forschungsgemeinschaft (DFG LE770/1-2) (A.L.).

The publication costs of this article were defrayed in part by payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 USC section 1734 solely to indicate this fact.


    Footnotes

Received June 11, 2001; revised version accepted September 28, 2001.

3 These authors contributed equally to this work.

4 Corresponding authors.

E-MAIL aleutz{at}mdc-berlin.de; FAX 49-30-9406-3298.

E-MAIL nerlov{at}embl-monterotundo.it; FAX 39-06-9009-1272.

Article and publication are at http://www.genesdev.org/cgi/doi/10.1101/gad.209901.


    References
Top
Abstract
Introduction
Results
Discussion
Materials and methods
References


GENES & DEVELOPMENT 15:3208-3216 © 2001 by Cold Spring Harbor Laboratory Press  ISSN 0890-9369/01 $5.00

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. V. Das, J. James, S. Bhattacharya, A. N. Imbalzano, M. L. Antony, G. Hegde, X. Zhao, K. Mallya, F. Ahmad, E. Knudsen, et al.
SWI/SNF Chromatin Remodeling ATPase Brm Regulates the Differentiation of Early Retinal Stem Cells/Progenitors by Influencing Brn3b Expression and Notch Signaling
J. Biol. Chem., November 30, 2007; 282(48): 35187 - 35201.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Zhang, H. Fang, J. Zhou, and B. P. Herring
A Novel Role of Brg1 in the Regulation of SRF/MRTFA-dependent Smooth Muscle-specific Gene Expression
J. Biol. Chem., August 31, 2007; 282(35): 25708 - 25716.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Sato, K. Miyake, H. Kaneoka, and S. Iijima
Sumoylation of CCAAT/Enhancer-binding Protein {alpha} and Its Functional Roles in Hepatocyte Differentiation
J. Biol. Chem., August 4, 2006; 281(31): 21629 - 21639.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. L. de la Serna, Y. Ohkawa, C. Higashi, C. Dutta, J. Osias, N. Kommajosyula, T. Tachibana, and A. N. Imbalzano
The Microphthalmia-associated Transcription Factor Requires SWI/SNF Enzymes to Activate Melanocyte-specific Genes
J. Biol. Chem., July 21, 2006; 281(29): 20233 - 20241.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
G.-L. Wang, X. Shi, E. Salisbury, Y. Sun, J. H. Albrecht, R. G. Smith, and N. A. Timchenko
Cyclin D3 Maintains Growth-Inhibitory Activity of C/EBP{alpha} by Stabilizing C/EBP{alpha}-cdk2 and C/EBP{alpha}-Brm Complexes.
Mol. Cell. Biol., April 1, 2006; 26(7): 2570 - 2582.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
B. T. Porse, T. A. Pedersen, M. S. Hasemann, M. B. Schuster, P. Kirstetter, T. Luedde, I. Damgaard, E. Kurz, C. K. Schjerling, and C. Nerlov
The Proline-Histidine-Rich CDK2/CDK4 Interaction Region of C/EBP{alpha} Is Dispensable for C/EBP{alpha}-Mediated Growth Regulation In Vivo
Mol. Cell. Biol., February 1, 2006; 26(3): 1028 - 1037.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
Y. Inayoshi, K. Miyake, Y. Machida, H. Kaneoka, M. Terajima, T. Dohda, M. Takahashi, and S. Iijima
Mammalian Chromatin Remodeling Complex SWI/SNF Is Essential for Enhanced Expression of the Albumin Gene during Liver Development
J. Biochem., February 1, 2006; 139(2): 177 - 188.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
X. Mo, E. Kowenz-Leutz, Y. Laumonnier, H. Xu, and A. Leutz
Histone H3 tail positioning and acetylation by the c-Myb but not the v-Myb DNA-binding SANT domain
Genes & Dev., October 15, 2005; 19(20): 2447 - 2457.
[Abstract] [Full Text] [PDF]